Aesthetic manufacturer Prollenium Medical Technologies has unveiled its latest dermal filler to the Revanesse range – Revise+.
According to the company, Revise+ is designed to address delicate areas like the tear trough. Formulated with high molecular weight hyaluronic acid (HA) and a concentration of 12mg HA/ml, it is ideal for periorbital treatment, notes the company.
According to the company, the filler is a soft and malleable gel with attributes that allow for minimal swelling, tissue integration and viscosity, making it ideal for superficial and deep filling in the periorbital area.
Oliver Ricard, head of international at Prollenium, said, “Revanesse Revise+ represents a significant advancement in the realm of HA fillers, born out of a collaboration with esteemed experts in the field of aesthetics. This innovative product addresses the previously unmet need for safely treating the challenging periorbital area.
